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Abstract
Conventional beam orientation optimization (BOO) algorithms for IMRT assume that the
same set of beam angles is used for all treatment fractions. In this paper we present a BOO
formulation based on group sparsity that simultaneously optimizes non-coplanar beam angles
for all fractions, yielding a fraction-variant (FV) treatment plan. Beam angles are selected by
solving a multi-fraction fluence map optimization problem involving 500-700 candidate beams
per fraction, with an additional group sparsity term that encourages most candidate beams to
be inactive. The optimization problem is solved using the Fast Iterative Shrinkage-Thresholding
Algorithm. Our FV BOO algorithm is used to create non-coplanar, five-fraction treatment
plans for prostate and lung cases, as well as a non-coplanar 30-fraction plan for a head and
neck case. A homogeneous PTV dose coverage is maintained in all fractions. The treatment
plans are compared with fraction-invariant plans that use a fixed set of beam angles for all
fractions. The FV plans reduced mean and max OAR dose on average by 3.3% and 3.7% of the
prescription dose, respectively. Notably, mean OAR dose was reduced by 14.3% of prescription
dose (rectum), 11.6% (penile bulb), 10.7% (seminal vesicle), 5.5% (right femur), 3.5% (bladder),
4.0% (normal left lung), 15.5% (cochleas), and 5.2% (chiasm). Max OAR dose was reduced
by 14.9% of prescription dose (right femur), 8.2% (penile bulb), 12.7% (proximal bronchus),
4.1% (normal left lung), 15.2% (cochleas), 10.1% (orbits), 9.1% (chiasm), 8.7% (brainstem), and
7.1% (parotids). Meanwhile, PTV homogeneity defined as D95/D5 improved from .95 to .98
(prostate case) and from .94 to .97 (lung case), and remained constant for the head and neck
case. Moreover, the FV plans are dosimetrically similar to conventional plans that use twice
as many beams per fraction. Thus, FV BOO offers the potential to reduce delivery time for
non-coplanar IMRT.
Keywords : Group sparsity, beam orientation optimization, proximal algorithms, non-coplanar IMRT
1 Introduction
Compared to coplanar IMRT and volumetric modulated arc therapy (VMAT), non-coplanar IMRT
with beam orientation optimization (BOO) has been shown to improve dose compactness and
organ-at-risk (OAR) sparing substantially for various cancer sites [1–8]. However, a large number
of non-coplanar beams (typically 15 or more) are needed to maximize dosimetric improvement,
resulting in a longer treatment time that may not be clinically viable. This problem is compounded
by the additional maneuvering of the gantry and couch that is needed for non-coplanar delivery.
To overcome this challenge, we examine a traditional but seemingly unnecessary constraint in
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radiotherapy planning — namely, the use of a fixed set of beam angles for all fractions of the
treatment course. By removing this constraint and utilizing different beam angles in different
fractions, the same dosimetric improvement may be achieved while using fewer beams per fraction,
thus avoiding long treatment delivery times.
The dosimetric benefit of spatiotemporally non-uniform fractionation schemes has been investi-
gated recently in the papers [9–11], which solve a BED-based multi-fraction fluence map optimization
problem to obtain treatment plans that deliver distinct dose distributions in different fractions.
Spatiotemporally modulated radiotherapy has also been investigated in the papers [12–15], which
optimize fractionation schedules based on a linear-quadratic cell survival model. However, in these
studies, the treatment plans are optimized using the same set of beams or VMAT arcs in all fractions,
and the idea of fraction-variant beam angle selection is not considered. Moreover, the motivation of
these studies is not to improve the cumulative physical dose distribution compared to conventional
planning methods but rather to improve the biological effectiveness, which may vary depending on
the underlying tumor biology.
In the context of proton therapy, a modality known as single-field uniform dose (SFUD) delivers
uniform and constant dose to the tumor using varying beam angles. Faced with a similar challenge
of minimizing the time for gantry rotation in proton therapy, SFUD delivery alternates between
several pre-selected beams and avoids high entrance dose to any particular volume [16]. In SFUD
planning, each field is independently optimized to cover the target uniformly, while OAR doses vary
between fields. In addition to providing for a shorter treatment delivery time, SFUD has been shown
to be more robust than multifield optimization intensity-modulated proton therapy (MFO-IMPT).
However, due to the more restrictive optimization space, SFUD dosimetry has been found inferior
to that of MFO-IMPT [17–20].
Despite this related work, we are not aware of any previous fraction-variant beam orientation
optimization studies. In this paper we investigate the potential improvement in cumulative physical
dose distribution from allowing beam orientations to vary between fractions. We present a BOO
formulation based on group sparsity that simultaneously optimizes non-coplanar beam angles for all
fractions, yielding fraction-variant treatment plans.
2 Methods
2.1 Notation
Before presenting a problem formulation for fraction-variant beam orientation optimization, we first
establish some notation.
• F is the total number of treatment fractions. We use F = 30 for conventional fractionation,
or F = 5 for SBRT.
• B is the number of candidate beams per fraction. Typically B is between 500 and 700 for
non-coplanar IMRT cases after colliding beams are removed. We assume that the pool of
candidate beam angles is the same for each fraction, but we make no requirement that the same
beam angles are used during each treatment session. The total number of candidate beams
(including all candidate beams from all fractions) is BF .
• The vector xf,b is the fluence map for the bth candidate beam on treatment day f .
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• The vector xf (for f = 1, . . . , F ) is the concatenation of the vectors xf,b, and the vector x is
the concatenation of the vectors xf :
xf =

xf,1
xf,2
...
xf,B
 and x =

x1
x2
...
xF
 .
• The matrix Ai =
[
A1i A
2
i · · · ABi
]
is the dose-calculation matrix for the PTV (when i = 0)
or for the ith OAR (i = 1, . . . , N). Here Abi is the block column of Ai corresponding to the
bth beam firing position. Note that Aixf =
∑B
b=1A
b
ixf,b is a vector that records how much
dose is delivered to each voxel of the ith structure on treatment day f .
• For i = 1, . . . , N , we define
A¯i =
[
Ai Ai · · · Ai
]︸ ︷︷ ︸
F copies of Ai
,
where the matrix Ai is repeated F times. A key point is that only one copy of Ai must be
stored in computer memory, so introducing A¯i does not increase RAM requirements. Notice
that the vector
A¯ix =
F∑
f=1
Aixf
stores the total dose delivered to each voxel in the ith OAR, summed over all treatment
fractions.
• The vector d0 stores the prescription doses for each voxel in the PTV, and the vectors di (for
i = 1, . . . , N) store prescribed maximum doses for each voxel in the ith OAR.
• The notation y+ (where y is a vector) is defined by y+ = max(y, 0), with the maximum taken
componentwise.
• The function ‖ · ‖(µ)1 is the Huber penalty (with parameter µ > 0), defined by
‖y‖(µ)1 =
∑
j
|yj |(µ), (1)
|yj |(µ) =
{
1
2µy
2
j if |yj | ≤ µ,
|yj | − µ2 otherwise.
The notation ‖ · ‖(µ)1 indicates that the Huber penalty is simply a smoothed out version of the
`1-norm, and µ controls the amount of smoothing.
• The matrix D represents a discrete gradient operator, so that Dx is a list of intensity differences
between adjacent beamlets. The function ‖Dx‖(µ)1 is a smoothed total variation regularization
penalty function. Total variation regularization has been used in fluence map optimization to
encourage fluence maps to be piecewise constant, which enhances plan deliverability [21–23].
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2.2 Fraction-variant beam orientation optimization
With the above notation in place, we are now ready to present a problem formulation for fraction-
variant (FV) beam orientation optimization. We propose to select beam orientations for all fractions
simultaneously by solving a multi-fraction fluence map optimization problem involving a large
number of candidate beams, with an additional group sparsity penalty term in the objective function
that encourages most candidate beams to be inactive. The group sparsity approach to beam
orientation optimization is an established technique that was introduced in [24] and was shown to
have state of the art performance in [25] and [26]. In detail, our FV BOO problem formulation is
minimize
x
F∑
f=1
η
2
‖A0xf − d0/F‖22︸ ︷︷ ︸
PTV
+
N∑
i=1
αi
2
‖(A¯ix− di)+‖22 +
βi
2
‖A¯ix‖22︸ ︷︷ ︸
OARs
(2)
+ γ‖Dx‖(µ)1︸ ︷︷ ︸
fluence map deliverability
+
F∑
f=1
B∑
b=1
wb‖xf,b‖p2︸ ︷︷ ︸
group sparsity
subject to x ≥ 0,
where 0 < p < 1. We take p = 1/2 for all experiments in this paper. (Our motivation for choosing
p = 1/2, as well as an explanation of why the value p = 1 is forbidden, is given in appendix B.) The
PTV terms encourage the PTV to be covered uniformly at each fraction, so that A0xf ≈ d0/F for
f = 1, . . . , F . The OAR terms (βi/2)‖A¯ix‖22 penalize the total dose delivered to OARs (summed over
all fractions), and the terms (αi/2)‖(A¯ix− di)+‖22 specifically penalize violations of the prescribed
dose limits A¯ix ≤ di for i = 1, . . . , N . The smoothed total variation regularization term γ‖Dx‖(µ)1
encourages all fluence maps for all fractions to be piecewise constant, for enhanced plan deliverability.
The group sparsity term encourages most candidate beams to be inactive, while allowing for a different
set of beams to be active at each fraction. The remaining active (nonzero) beams for each fraction
are the ones selected to be used during treatment. In practice we find that approximately the same
number of beams are selected for each fraction, although this requirement is not enforced explicitly.
The weights wb can be chosen to be all the same, so that wb = c for all b, with the constant c tuned
to control the number of active beams in the solution to (2). Alternatively, the weights wb can
be computed (as a preprocessing step) according to the strategy explained in appendix C. Either
way, the weights wb do not have to be tuned individually. Once the beam angle selection step is
complete, fluence maps for all selected beams (for all fractions) are computed simultaneously by
solving a multi-fraction fluence map optimization problem which is similar to problem (2), but with
no group sparsity term and using only the beams which were selected for each fraction.
2.3 Optimization algorithm
We solve the optimization problem (2) using an accelerated proximal gradient method known as
the Fast Iterative Shrinkage-Thresholding Algorithm (FISTA) [27,28]. FISTA solves optimization
problems of the form
minimize
x∈Rn
g(x) + h(x), (3)
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Algorithm 1 FISTA with line search
Initialize x0 and t0 > 0, set v0 := x0, select 0 < r < 1, s > 1
for k = 1, 2, . . . do
t := s tk−1
repeat
θ :=
{
1 if k = 1
positive root of tk−1θ2 = tθ2k−1(1− θ) if k > 1
y := (1− θ)xk−1 + θvk−1
x := proxth(y − t∇g(y))
break if g(x) ≤ g(y) + 〈∇g(y), x− y〉+ 12t‖x− y‖22
t := rt
tk := t
θk := θ
xk := x
vk := xk−1 + 1θk (xk − xk−1)
end for
where the convex function g is assumed to be differentiable (with a Lipschitz continuous gradient)
and the function h is assumed to “simple” in the sense that its proximal operator can be evaluated
efficiently. The proximal operator (also known as “prox-operator”) of h, with parameter t > 0, is
defined by
proxth(x) = arg min
u
h(u) +
1
2t
‖u− x‖22. (4)
Problem (2) has the form (3), where
g(x) =
F∑
f=1
η
2
‖A0xf − d0/F‖22 +
N∑
i=1
(
αi
2
‖(A¯ix− di)+‖22 +
βi
2
‖A¯ix‖22
)
+ γ‖Dx‖(µ)1
and
h(x) =
{∑F
f=1
∑B
b=1wb‖xf,b‖p2 if x ≥ 0,
∞ otherwise. (5)
The function h enforces the constraint x ≥ 0 by returning the value ∞ when this constraint is not
satisfied. Standard convergence results for FISTA assume that h is convex, but we have found that
FISTA converges to a good solution when p = 1/2, in which case h is not convex.
The FISTA with line search algorithm is recorded in algorithm 1. The key steps in each iteration
of FISTA are to evaluate the gradient of g and the proximal operator of h. To compute the gradient
of g, we first note three facts that can be shown using basic calculus:
1. If G(y) = 12‖y‖22, then ∇G(y) = y.
2. If G(y) = 12‖y+‖22, then ∇G(y) = y+ = max(y, 0) (with maximum taken componentwise).
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3. If G is the Huber penalty function G(y) = ‖y‖(µ)1 (defined in equation (1)), then ∇G(y) =
1
µP[−µ,µ](y), where P[−µ,µ](y) is the projection of the vector y onto the set {u | −µ ≤ u ≤
µ}. (The inequalities are interpreted componentwise.) Projecting onto this set is a simple
componentwise “clipping” operation.
It now follows from the chain rule that
∇g(x) =
F∑
f=1
ηAT0 (A0xf − d0/F ) +
N∑
i=1
αiA¯
T
i (A¯ix− di)+ + βiA¯Ti A¯ix
+
γ
µ
DTP[−µ,µ](Dx). (6)
To state a formula for the prox-operator of h, in the special case that p = 1/2, we first express h
as h(x) =
∑F
f=1
∑B
b=1 hf,b(xf,b), where
hf,b(xf,b) =
{
wb‖xf,b‖p2 if xf,b ≥ 0,
∞ otherwise.
(Recall that the vector xf,b is the fluence map for beam b on treatment day f , and x is the
concatenation of the vectors xf,b.) The vector proxth(x) has the same size and block structure as x,
and the separable sum rule for prox-operators [29] informs us that the (f, b)th block of proxth(x) is
given by
[proxth(x)]f,b = proxthf,b(xf,b). (7)
We show in appendix A that
proxthf,b(xf,b) = proxtwb‖·‖p2(max(xf,b, 0)). (8)
Here proxtwb‖·‖p2 denotes the prox-operator of the function ‖x‖
p
2 with parameter twb. An explicit
formula for this prox-operator in the special case that p = 1/2 is given in appendix A. Using
formulas (6), (7), and (8) to compute the gradient of g and the prox-operator of h, it is now
straightforward to solve problem (2) using the FISTA with line search algorithm 1.
2.4 Experimental setup
Case Prescription dose (Gy) PTV volume (cc)
PRT 40 111.2
LNG 48 72.3
H&N 66 33.6
Table 1: Prescription dose and PTV volume for prostate, lung, and head and neck patients.
An SBRT prostate, an SBRT lung, and a conventionally fractionated head and neck patient
with a single-level prescription dose to the unilateral lesion were selected to test and evaluate the
proposed algorithm. The prescription doses and PTV volumes for each case are listed in table 1.
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Case
Num.
fractions
Num. candidate
beams per fraction
Total num.
beamlets
Avg. num. of beams
selected per fraction
Runtime
(hrs)
PRT 5 674 569,770 9.6 1.5
LNG 5 520 347,240 6.6 1.1
H&N 30 741 2,013,870 6.36 6.6
Table 2: Number of fractions, number of candidate beams per fraction, total number of beamlets
(for all candidate beams in all fractions), average number of beams selected per fraction, and FISTA
runtimes for cases “PRT”, “LNG”, and “H&N”.
For each case, we began with 1162 candidate beam firing positions evenly distributed over the
surface of a sphere, with approximately six degrees of separation between adjacent beams. A 3D
human surface measurement and a machine CAD model were utilized to identify collision zones, and
beam angles that resulted in collisions were removed. As a result, 500-700 non-coplanar candidate
beam firing positions, as reported in table 2, were retained for dose calculation and optimization.
Beamlet dose was calculated for all beams within the conformal aperture +5 mm margin using
convolution/superposition with a 6 MV polyenergetic kernel [30]. The dose calculation resolution
was isotropically 2.5 mm. The MLC leaf width at the isocenter was assumed to be 5 mm.
For each of the three cases, problem (2) was solved using the FISTA with line search algorithm 1.
The weight parameters η, αi, βi, and γ appearing in the penalty functions and the vectors di were
tuned on a case by case basis to achieve high quality treatment plans. The Huber penalty smoothing
parameter µ was set to 1. The beam weights wb were chosen as in equation (13), with the parameter
c in (13) tuned to yield a reasonable number of active beams per fraction. The optimization variable
x was initialized randomly with components between 0 and 1, drawn independently from a uniform
distribution. The parameters r and s in algorithm 1 were taken to be r = .5 and s = 1.25. In each
case FISTA was run for 5000 iterations, which was sufficiently many for the algorithm to converge
on a stable selection of beams for each fraction. The FISTA runtimes are shown in table 2.
The resulting FV treatment plans were compared with treatment plans that are conventional
in the sense that they use a fixed set of beam angles and fluence maps for all fractions. The
conventional plans were computed by taking F = 1 in problem (2). (These conventional plans
will sometimes be described as fraction-invariant (FI) to emphasize that they are not FV.) For
each case, the conventional plans were computed using identical OAR weights as were used for the
fraction-variant plan, except that for case “H&N” the skin structure weighting was increased when
computing the FI plans to prevent unacceptable hot spots on the skin.
For plan comparison, PTV D98, D99, and PTV homogeneity defined as D95/D5 were evaluated.
All treatment plans were scaled so that PTV D95 was equal to the prescription dose. OAR max
and mean dose, denoted by DFVmax and D
FV
mean for the fraction-variant plans and D
FI
max and D
FI
mean
for the fraction-invariant plans, were also calculated for assessment. For each OAR, the difference
in max dose and the difference in mean dose between the two plans were computed. Max dose is
defined as the dose at 2 percent of the structure volume, D2, which is recommended by the ICRU-83
report [31].
All treatment plans were created on a computer with two Intel Xeon CPU E5-2687W v3 3.10 GHz
processors and 512 GB of RAM.
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3 Results
(a) (b) (c)
Figure 1: (a) and (b) Fraction-variant treatment plans for each of five fractions for cases “PRT”
and “LNG”. The PTV receives a uniform dose of 8 Gy (approximately) at each fraction for case
“PRT” and 9.6 Gy (approximately) for case “LNG”. (c) Dose colormaps for fractions 1, 7, 13, 19,
and 25 for case “H&N”. The PTV receives a uniform dose of 2.2 Gy (approximately) throughout
the treatment course.
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3.1 Prostate case
Figure 1(a) shows dose colormaps for each of the five fractions for the FV prostate plan. Notice
that despite the variation in dose distributions, the PTV is covered uniformly in all fractions. Each
voxel in the PTV receives a dose of approximately 40/5 = 8 Gy per fraction. Figure 2 visualizes the
beam angles that were selected for each of five fractions for the prostate case using the FV BOO
algorithm. Each beam is specified by a couch angle and a gantry angle. The FV BOO algorithm
selected 9.6 beams per fraction, on average. As expected, the algorithm did not select the same set
of beam angles for each fraction. In fact, a total of 44 distinct beam firing positions were utilized,
as visualized in figure 2(f).
(a) Fraction 1 (b) Fraction 2 (c) Fraction 3
(d) Fraction 4 (e) Fraction 5 (f) All fractions
Figure 2: (a) - (e) Beam angles selected for each of five fractions for prostate case “PRT”. On
average 9.6 beams per fraction were selected. (f) A total of 44 distinct beam firing positions were
utilized for case “PRT”.
Figure 3 shows the total dose distribution, summed over all five fractions, for the FV plan (top
row) as well as a conventional 10-beam FI plan (middle row) and a conventional 20-beam FI plan
(bottom row). Corresponding dose-volume histograms, comparing the FV plan with the two FI
beam plans, are shown in figure 4. Compared with the 10-beam FI plan, the FV plan achieves
dosimetric improvements for all OARs except the left femur, which receives similar low doses in both
plans. The dosimetric improvement to the anterior rectum is particularly evident. Mean dose was
reduced by 5.7 Gy (rectum), 4.6 Gy (penile bulb), 4.3 Gy (seminal vesicle), and 1.4 Gy (bladder).
Max dose was reduced by 6.0 Gy (right femur), 3.3 Gy (penile bulb), and 1.3 Gy (seminal vesicle).
The PTV coverage is more homogeneous for the FV plan. The dosimetric quality of the FV plan is
similar to that of the 20-beam FI plan, despite the fact that the FV plan uses only half as many
beams per fraction.
9
Figure 3: Visualizing the dose distribution (summed over all five fractions) for FV plan using average
of 9.6 beams per fraction (top row) as well as a 10-beam FI plan (middle row) and a 20-beam FI
plan (bottom row). Dose below 5 Gy is not shown.
(a) (b)
Figure 4: Dose volume histograms for prostate case “PRT”, comparing FV plan that uses 9.6 beams
per fraction (solid) with FI plans (dotted) using (a) 10 beams, and (b) 20 beams.
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3.2 Lung case
Figure 1(b) shows dose colormaps for each of the five fractions for the FV lung plan. Despite the
variation in dose distributions, the PTV is covered uniformly at each fraction. Each voxel in the
PTV receives a dose of approximately 48/5 = 9.6 Gy per fraction. Figure 5 shows the beam angles
that were selected for each of five fractions for the lung case using the FV BOO algorithm. On
average, only 6.6 beams per fraction were selected. Again, the algorithm did not select the same set
of beam angles for any two fractions. A total of 27 distinct beam firing positions were utilized, as
visualized in figure 5(f).
(a) Fraction 1 (b) Fraction 2 (c) Fraction 3
(d) Fraction 4 (e) Fraction 5 (f) All fractions
Figure 5: (a) - (e) Beam angles selected for each of five fractions for lung case “LNG”. On average
6.6 beams per fraction were selected. (f) Although only 6.6 beams were selected per fraction (on
average), a total of 27 distinct beam firing positions were utilized for case “LNG”.
Figure 6 shows the total dose distribution, summed over all five fractions, for the FV plan (top
row) as well as a conventional 7-beam FI plan (middle row) and a conventional 13-beam FI plan
(bottom row). Corresponding dose-volume histograms, comparing the FV plan with the two FI
plans, are shown in figure 7. Compared with the 7-beam FI plan, the FV plan achieves dosimetric
improvements for the proximal bronchus and the normal left lung. Mean dose was reduced by 1.9 Gy
for the normal left lung, while max dose was reduced by 6.0 Gy for the proximal bronchus and by
2.0 Gy for the normal left lung. The R50 values are 2.98 for the FV plan, 4.12 for the 7-beam FI
plan, and 3.25 for the 13-beam FI plan. This substantial improvement in dose compactness for the
FV plan can be visually appreciated in figure 6. The dosimetric quality of the FV plan is similar to
that of the 13-beam FI plan, while using only half as many beams per fraction.
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Figure 6: The dose distribution (summed over all five fractions) for FV plan with average of 6.6
beams per fraction (top row) as well as a 7-beam FI plan (middle row) and a 13-beam FI plan
(bottom row). Dose below 5 Gy is not shown.
(a) (b)
Figure 7: Dose volume histograms for lung case “LNG”, comparing FV plan that uses 6.6 beams
per fraction (solid) with FI plans (dotted) using (a) 7 beams, and (b) 13 beams.
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3.3 Head and neck case
Figure 1(c) shows the dose distributions for a selection of five of the 30 treatment fractions for the
FV head and neck plan. Despite the variation in dose distributions, the PTV is covered uniformly at
each fraction. Each voxel in the PTV receives a dose of approximately 66/30 = 2.2 Gy per fraction.
The FV BOO algorithm selected only 6.36 beams per fraction, on average. As in all cases, the
algorithm did not select the same set of beam angles for any two fractions. A total of 81 distinct
beam firing positions were utilized, as illustrated in figure 8(f).
(a) Fraction 1 (b) Fraction 7 (c) Fraction 13
(d) Fraction 19 (e) Fraction 25 (f) All fractions
Figure 8: (a) - (e) Beam angles selected for five of the 30 treatment fractions for head and neck case
“H&N”. (f) Although only 6.36 beams were selected per fraction (on average), a total of 81 distinct
beam firing positions were utilized for case “H&N”.
Figure 9 shows the total dose distribution, summed over all 30 fractions, for the FV plan (top
row) as well as a 7-beam FI plan (middle row) and a 13-beam FI plan (bottom row). Corresponding
dose-volume histograms are shown in figure 10. Compared with the 7-beam FI plan, the FV plan
achieves dosimetric improvements for the cochleas (bilateral), chiasm, brainstem, parotids, and
orbits. Mean dose was reduced by 10.2 Gy (cochleas), 3.4 Gy (chiasm), 1.2 Gy (brainstem), and
1.0 Gy (orbits). Max dose was reduced by 10.0 Gy (cochleas), 6.7 Gy (orbits), 5.7 Gy (brainstem),
4.7 Gy (parotids), 1.6 Gy (brain), and 1.4 Gy (pharynx). The dosimetric quality of the FV plan is
comparable to that of the 13-beam FI plan.
3.4 Plan quality metrics
Tables 3 and 4 show treatment plan quality metrics for the three cases listed in table 1. For each
case, metrics are reported for the FV plan as well as for the corresponding FI plan that uses
approximately the same number of beams per fraction as the FV plan. (So for cases “LNG” and
13
Figure 9: Visualizing the dose distribution (summed over all 30 fractions) for FV plan with average
of 6.36 beams per fraction (top row) as well as a 7-beam FI plan (middle row) and a 13-beam FI
plan (bottom row). Dose below 5 Gy is not shown.
Case D95 (Gy) D98 (Gy) D99 (Gy) Dmax HI
PRT 40.0 [40.0] 39.8 [39.9] 39.6 [39.8] 40.9 [42.6] .98 [.95]
LNG 48.0 [48.0] 47.6 [47.8] 47.1 [47.7] 49.6 [51.23] .97 [.94]
H&N 66.0 [66.0] 65.3 [65.6] 64.5 [65.2] 67.9 [68.3] .97 [.97]
Table 3: PTV coverage metrics for several cases. FV BOO results are shown in black, FI plan
results in blue. The homogeneity index HI is defined as D95/D5.
“H&N” the FV plan is compared against the 7-beam FI plan, and for case “PRT” the FV plan is
compared against the 10-beam FI plan.) The FV plans show improvement in PTV Dmax in all cases,
as well as improvements in PTV homogeneity (defined as D95/D5) for cases “PRT” and “LNG”.
There is a slight decrease in PTV D98 and D99.
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(a) (b)
Figure 10: Dose volume histograms for head and neck case “H&N”, comparing FV plan that uses
6.36 beams per fraction (solid) with FI plans (dotted) using (a) 7 beams, and (b) 13 beams.
DFVmean −DFImean DFVmax −DFImax
Case average (Gy) range (Gy) average (Gy) range (Gy)
PRT -3.0 [−5.7, .24] -1.8 [−6.0, .49]
LNG -.27 [−1.9, .47] -.25 [−6.1, 2.7]
H&N -1.5 [−10.2, 2.3] -3.4 [−10.0, 6.2]
Table 4: OAR dose differences for several cases. For each case, the difference in mean dose
DFVmean −DFImean is computed for all OARs. The min, max, and average differences in mean dose are
listed in columns 2 and 3. Likewise, the min, max, and average values of DFVmax −DFImax are listed in
columns 4 and 5.
For a given OAR, let DFVmean and D
FI
mean denote the mean doses delivered to the OAR by the FV
plan and FI plans, respectively. Let DFVmax and D
FI
max denote the maximum doses delivered to the
OAR by the respective plans. For each case, we computed the difference in mean dose (that is,
DFVmean −DFImean) and the difference in max dose (that is, DFVmax −DFImax) for each OAR. The results
are summarized in table 4.
4 Discussion
By allowing beam angles to vary between fractions, FV BOO exploits degrees of freedom in IMRT
which have traditionally been underutilized. As demonstrated by the results in section III, FV plans
are able to improve dosimetry without increasing the number of beams per fraction, or alternatively
to reduce the number of beams per fraction without compromising dosimetry. The FV BOO strategy
addresses a main criticism of non-coplanar IMRT treatment plans, which is the long delivery time
due to the large number of static beams required to sufficiently sample the vast non-coplanar beam
angle space. FV BOO offers the potential to reduce this delivery time by using fewer beams per
fraction, while still utilizing a large total number of non-coplanar beam angles. An excellent example
15
is provided by the improvement in dose compactness observed in case “LNG” in section 3. It was
shown in [3] that for lung SBRT cases non-coplanar IMRT yields a substantial improvement in
dose compactness as measured by R50, but to achieve this improvement it was necessary to utilize
well more than 10 non-coplanar beam angles. In the lung SBRT case “LNG” studied here, the FV
approach was able to achieve superior dose compactness while using half as many beams per fraction
as the FI plan. Therefore, the FV planning method removes a major roadblock to implementing 4pi
non-coplanar radiotherapy.
This study is novel in optimizing all beams for the entire plan simultaneously yet allowing
different sets of beam angles to be used in different fractions. Aside from this central point, a
key detail which distinguishes our approach is that the PTV is covered homogeneously in each
fraction. In contrast, the spatiotemporally non-uniform fractionation schemes studied in [9–11]
target subregions of the PTV at each fraction. While that is an effective strategy for BED-based
optimization, questions remain about the robustness of the resulting plans against setup error,
and further work is needed to validate the biological effect of the heterogeneous PTV doses on
tumor growth. Thus, the FV BOO approach which maintains a uniform tumor dose coverage is
potentially more clinically translatable. FV BOO bears a conceptual similarity to SFUD planning.
However, the ability of FV BOO to optimize all candidate beams together clearly distinguishes the
two methods.
This work is only a first step towards fraction-variant beam orientation optimization, and there
is likely room for improvement in both the problem formulation and the optimization algorithm.
For example, if the per fraction dose to certain OARs poses a concern, the objective function can
be modified to enforce fraction-wise OAR control:
minimize
x
F∑
f=1
12‖A0xf − d0/F‖22 +
N∑
i=1
αi
2
‖(Aixf − di)+‖22︸ ︷︷ ︸
controls fractional doses to PTV and OARs
 (9)
+
N∑
i=1
βi
2
‖A¯ix‖22︸ ︷︷ ︸
controls total dose to OARs
+ γ‖Dx‖(µ)1︸ ︷︷ ︸
fluence map deliverability
+
F∑
f=1
B∑
b=1
wb‖xf,b‖1/22︸ ︷︷ ︸
group sparsity
subject to x ≥ 0.
An additional area for improvement is the optimization runtime, which in our experiments
is about 60-90 minutes for non-coplanar five fraction plans and about 7 hours for non-coplanar
30 fraction plans (with 500-700 candidate beams per fraction). The computational expense for
each FISTA iteration is dominated by matrix-vector multiplications involving the large sparse
matrices Ai and A
T
i . These matrix-vector multiplications could be made much faster with a GPU
implementation. Besides improving the implementation, it may be possible to improve the algorithm
as well. While we have found FISTA to be effective for this application, other algorithms should
be investigated, such as truncated interior point methods [32–34], or recently developed proximal
quasi-Newton methods [35–37]. New algorithmic innovations such as performing column clustering
on the dose-calculation matrix to reduce the problem size, as suggested in [38], will likely be
beneficial. Note that we have found that if the OAR weights αi and βi are tuned for the case
where there is only one treatment fraction, then the same weights tend to yield a good selection of
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beams for the full fraction-variant problem with F fractions. This is very helpful because in our
experiments it only takes about 5-8 minutes to solve problem (2) when F = 1.
One potential burden of fraction-variant BOO is increased patient-specific IMRT quality assurance
(QA) load. It would be time-consuming to QA all individual fractions. Measurement of individual
beams may be feasible but may lead to difficulty in analyzing the results because of the non-uniform
target dose resulting from a single beam. However, this is unlikely to be an insurmountable difficulty
as machine log file analysis in combination with independent dose calculation has shown efficacy
equivalent to measurement-based QA [39].
5 Conclusions
This work demonstrates the first beam orientation optimization algorithm that simultaneously
optimizes beam angles for all IMRT treatment fractions. The resulting fraction-variant plans offer
improved dosimetry without increasing the beam budget (that is, the number of beams per fraction
that are utilized). Alternatively, fraction-variant plans allow the beam budget to be reduced without
compromising dosimetry.
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A Prox-operator calculation
Here we derive a formula for the prox-operator of the function h : Rn → R ∪ {∞} defined by
h(x) =
{
‖x‖p2 if x ≥ 0
∞ otherwise,
in the special case where p = 1/2. (The inequality x ≥ 0 is interpreted componentwise.) Let t > 0.
To evaluate proxth(xˆ), we must find the minimizer for the optimization problem
minimize
x
‖x‖p2 +
1
2t
‖x− xˆ‖22 (10)
subject to x ≥ 0.
First note that if xˆi ≤ 0 then there is no benefit from taking the component xi to be positive. If xi
were positive, then both terms in the objective function could be reduced just by setting xi = 0.
It remains only to select values for the other components of x. This is a smaller optimization
problem, with one unknown for each positive component of xˆ. The negative components of xˆ are
17
irrelevant to the solution of this reduced problem. Thus, we would still arrive at the same final
answer if the negative components of xˆ were set equal to 0 at the very beginning.
In other words, problem (10) is equivalent to the problem
minimize
x
‖x‖p2 +
1
2t
‖x−max(xˆ, 0)‖22
subject to x ≥ 0,
which in turn is equivalent to the problem
minimize
x
‖x‖p2 +
1
2t
‖x−max(xˆ, 0)‖22
(because there would be no benefit from taking any components of x to be negative). This shows
that
proxth(xˆ) = proxt‖·‖p2(max(xˆ, 0)). (11)
Formula (11) is valid for any p > 0. The reason we take p = 1/2 is that a short and explicit
(but non-obvious) formula for the prox-operator of the function ψ(y) = ‖y‖1/22 is available [40]. To
evaluate proxtψ(y), first let α = t/‖y‖3/22 . (If y = 0 then α =∞.) Then
proxtψ(y) = s
2y, where s =
{
2√
3
sin(13 arccos(
3
√
3
4 α) +
pi
2 ) if α ≤ 2
√
6
9 ,
0 otherwise.
(12)
B The choice of group sparsity exponent p.
Here we explain why the choice p = 1 for the exponent in the group sparsity penalty function is
forbidden. Suppose we take p = 1, so that problem (2) is convex, and let x? be a minimizer for (2).
The blocks of x? are denoted x?1, . . . , x
?
F . We can obtain another minimizer for problem (2) by
permuting the blocks of x?. In other words, the vector x?σ defined by
x?σ =

x?σ(1)
x?σ(2)
...
x?σ(F )

is optimal for (2) for any permutation σ of {1, 2, . . . , F}. In fact, if SF is the set of all permutations
of {1, . . . , F}, then any convex combination of vectors x?σ (with σ ∈ SF ) is optimal as well:
xθ =
∑
σ∈SF
θσx
?
σ
is optimal for problem (2) whenever
∑
σ∈SF θσ = 1 and θσ ≥ 0 for all σ ∈ SF . An optimization
algorithm that finds a global minimizer for problem (2) (with p = 1) will almost surely find one of
the solutions xθ with θσ > 0 for all σ ∈ SF , and such a solution has the same set of active beams
for each fraction. We have observed this phenomenon in numerical experiments. Thus, FV BOO
requires the use of a non-convex group sparsity penalty term. We choose p = 1/2 specifically because
the proximal operator of the function ψ(x) = ‖x‖1/22 can be evaluated easily using formula (12) in
appendix A.
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C Selecting the weights wb in the group sparsity term.
In this section we explain our method for choosing the weights wb that appear in the group sparsity
term in problem (2). Some beams must only travel a short distance through the body to reach the
PTV, whereas other “long path” beams must travel a greater distance through the body before
reaching the PTV. To overcome attenuation, a “long path” beam must be fired more intensely than
a short path beam in order to deliver the same dose to the PTV. If all the weights wb in the group
sparsity term are chosen to be equal, then the group sparsity penalty introduces a bias in favor of
short path beams, because a long path beam b requires ‖xb‖2 to be large in order to target the PTV
effectively. We choose the weights wb to compensate for this bias.
Let nb be the number of beamlets in beam b with a trajectory that intersects the PTV. Suppose
that beam b is fired uniformly, so that xb = λ~1, and the scalar λ is chosen so that the mean dose
delivered to the PTV by beam b is 1 Gy. Then it is easy to check that ‖xb‖p2 =
(√
nb/mean(A
b
0
~1 )
)p
,
where Ab0 is the dose-calculation matrix from beam b to the PTV. This quantity is larger for long
path beams than for short path beams. Therefore, to level the playing field, we choose the weights
wb so that
wb = c
(
mean(Ab0~1 )√
nb
)p
. (13)
The scalar c is chosen to be the same for all beams, and c is tuned by trial and error to achieve the
desired group sparsity level.
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